Real Madrid top Deloitte Football Money League as Champions League revamp boosts Premier League’s rivals
Glaxosmithkline signs $2bn cancer treatment deal with US biotech firm June 15, 2021 Glaxosmithkline has agreed to pay a US biotech firm as much as $2.1bn (£1.5bn) to team up on an experimental new cancer treatment. The British pharma giant will pay iTeos Therapeutics $625m upfront to co-develop and co-commercialise an immuno-oncology drug known as EOS-448. iTeos will be entitled to receive up to a further $1.5bn if [...]
GSK granted US FDA approval for Covid-19 antibody drug May 27, 2021 GSK granted US FDA approval for Covid-19 antibody drug
Top shareholders offer support to GSK following activist hedge fund investment May 17, 2021 Several of GlaxoSmithKline’s top shareholders have contacted its chairman to offer support, following concerns activist hedge fund Elliott Management is preparing to push for a shake-up at the group. Shareholders including BlackRock, Dodge & Cox and Royal London are said to have given their support, the Times first reported. The pharma giant has come under [...]
GSK profit drops sharply due to pandemic but beats forecasts April 28, 2021 Pharma giant GSK saw its profit and turnover slip in the first quarter due to the impact of the coronavirus pandemic, but came in ahead of analyst expectations. The FTSE 100 firm said that adjusted operating profit fell 30 per cent in the period, down to £1.9bn. Turnover slid 18 per cent to £7.4bn, it [...]
GlaxoSmithKline share price leaps at news of activist hedge fund interest April 16, 2021 Shares in GlaxoSmithKline continued to rise on Friday after it emerged that activist hedge fund Elliot Management had built a large stake in the company. New York-based firm Elliot Management, run by billionaire Paul Singer, is believed to have made the multibillion-pound investment earlier this week. GSK was one of the FTSE 100’s biggest risers [...]
The week ahead, 1-5 February: FTSE heavyweights front up to third lockdown January 31, 2021 After a turbulent opening to 2021, with new Covid-19 lockdowns around the world, spats over “vaccine nationalism”, and chaos on both Wall Street and Pennsylvania Avenue, a slew of FTSE heavyweights are set to update the market in what will be a crunch week for London’s indices. Despite a strong opening week, the FTSE 100 [...]
Asian consumers, boomerang businesses and M&A likely to shape 2021 January 6, 2021 It was some year. Anyone who took on the challenge of forecasting what would happen in 2020 more than likely saw it all swiftly swept aside – but, as they say, prediction is very difficult, especially when it’s about the future. Still, investing is a forward-looking profession and so we inevitably find ourselves thinking about [...]
How close are we to having an approved coronavirus vaccine? October 28, 2020 There are a number of vaccine programmes which have advanced to stage three trials, the final hurdle before approval, including two based in the UK. How are they progressing?
GSK profit falls a fifth in the third quarter October 28, 2020 Glaxosmithkline (GSK) saw profit attributable to shareholders slip nearly a fifth in the third quarter, but said it was on track to deliver on its guidance for the year. The update came after the pharma giant announced that it would provide a global coronavirus vaccine programme with 200m doses of its candidate. Over the three [...]
GSK and Sanofi begin human trials of coronavirus vaccine September 3, 2020 Glaxosmithkline (GSK) has today announced that it is beginning human trials of the coronavirus vaccine it is developing with French pharma firm Sanofi. The two joined forces back in April to develop the potential vaccine, testing of which is now ready to move to the next stage after promising initial results. The combined phase 1 [...]